Why Noradrenaline Should Not Be Bolused
Norepinephrine (noradrenaline) must be administered only as a continuous infusion, never as a bolus, because of the risk of potentially lethal arrhythmias, severe hypertension, and unpredictable hemodynamic responses that cannot be rapidly reversed given the drug's pharmacological properties.
Pharmacological Rationale
Norepinephrine is an extremely potent vasopressor with both alpha-1 (vasoconstriction) and beta-1 (cardiac stimulation) adrenergic effects. When given as a bolus:
Arrhythmia Risk: The FDA drug label explicitly warns that intravenous epinephrine (and by extension, norepinephrine) carries "risk for potentially lethal arrhythmias" 1. The sudden surge in catecholamine levels can trigger ventricular tachycardia or fibrillation, particularly in patients with underlying cardiac irritability, hypoxia, or hypercarbia 2.
Uncontrolled Hypertension: Bolus administration creates dangerously high peak drug concentrations that can produce severe hypertensive crises. The FDA label emphasizes that "the possibility always exists that dangerously high blood pressure may be produced with overdoses of this pressor agent" 1. Unlike an infusion that can be immediately stopped or titrated, a bolus cannot be reversed once administered.
Inability to Titrate: The FDA explicitly states that "the rate of flow must be watched constantly" and recommends blood pressure monitoring "every two minutes from the time administration is started until the desired blood pressure is obtained" 1. This level of precise control is impossible with bolus dosing.
Clinical Practice Standards
Approved Administration Methods
Continuous infusion is the only recommended route 1:
- Starting dose: 0.5 mg/hour (or 2-4 mcg/min), titrated every 4 hours by 0.5 mg/hour increments up to maximum 3 mg/hour 3
- Alternative dosing: 0.05-0.1 mcg/kg/min peripherally 4
- The drug must be diluted in dextrose-containing solutions (typically 4 mg in 1000 mL yielding 4 mcg/mL) 1
Specific Clinical Contexts
The evidence shows limited exceptions where very small, carefully controlled IV doses may be used:
In anaphylaxis refractory to multiple IM epinephrine doses: Aqueous epinephrine 1:1000,0.1-0.3 mL in 10 mL normal saline can be administered IV "over several minutes" only in profoundly hypotensive patients who have failed volume replacement and several injected doses 5. However, this refers to epinephrine, not norepinephrine, and even then continuous hemodynamic monitoring is essential.
In perioperative allergic reactions: Grade II-III reactions may receive small IV epinephrine boluses (20-200 mcg) 4, but again this is epinephrine with its different receptor profile, not norepinephrine.
In obstetric spinal anesthesia: Recent research explored intermittent norepinephrine boluses of 3-8 mcg to prevent hypotension during cesarean delivery 6. However, this highly specialized context involves:
- Prophylactic use in healthy parturients
- Extremely small doses (ED90 of 5.49 mcg)
- Immediate availability of monitoring and resuscitation
- This remains investigational and not standard practice
Why Continuous Infusion Is Superior
Precise hemodynamic control: Continuous infusion allows minute-to-minute titration to achieve target mean arterial pressure (typically ≥65 mmHg) while avoiding excessive vasoconstriction 3, 7.
Predictable pharmacokinetics: Norepinephrine has a very short half-life (2-3 minutes). Continuous infusion maintains steady-state levels, while boluses create unpredictable peaks and troughs.
Safety monitoring: The FDA mandates that patients "should never be left unattended while receiving LEVOPHED" 1. Continuous infusion with pump delivery allows for constant rate adjustment and immediate cessation if adverse effects occur.
Microcirculatory optimization: Recent evidence suggests that perfusion-guided titration of continuous norepinephrine infusion, rather than fixed MAP targets, may optimize tissue perfusion 8. This nuanced approach is impossible with bolus dosing.
Common Pitfalls to Avoid
- Never administer undiluted norepinephrine: Always dilute in dextrose-containing solutions 1
- Avoid peripheral extravasation: While peripheral administration is increasingly accepted as safe 9, 10, extravasation requires immediate treatment with phentolamine 0.1-0.2 mg/kg diluted in 10 mL saline injected intradermally at the site 2
- Do not confuse with epinephrine protocols: Epinephrine may be given as boluses in cardiac arrest (1 mg every 3-5 minutes) 2, but norepinephrine lacks this indication
- Avoid in patients on MAOIs: Severe, prolonged hypertension may result from the interaction 1
The fundamental principle is that norepinephrine's potency and potential for life-threatening complications demand the precise control that only continuous infusion can provide.